MENU
+Compare
ARGX
Stock ticker: NASDAQ
AS OF
Aug 20, 01:57 PM (EDT)
Price
$657.94
Change
+$1.05 (+0.16%)
Capitalization
41.08B

ARGX argenx SE Forecast, Technical & Fundamental Analysis

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARGX with price predictions
Aug 19, 2025

ARGX in +1.36% Uptrend, rising for three consecutive days on August 18, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ARGX advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ARGX moved above its 50-day moving average on July 21, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ARGX crossed bullishly above the 50-day moving average on July 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 242 cases where ARGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ARGX moved out of overbought territory on August 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where ARGX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ARGX as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ARGX turned negative on August 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARGX broke above its upper Bollinger Band on July 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.640) is normal, around the industry mean (19.363). P/E Ratio (33.655) is within average values for comparable stocks, (50.340). ARGX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.941). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (14.793) is also within normal values, averaging (299.736).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARGX is expected to report earnings to fall 27.85% to $4.56 per share on October 30

argenx SE ARGX Stock Earnings Reports
Q3'25
Est.
$4.56
Q2'25
Beat
by $3.26
Q1'25
Beat
by $0.34
Q4'24
Beat
by $10.57
Q3'24
Beat
by $1.24
The last earnings report on July 31 showed earnings per share of $6.32, beating the estimate of $3.06. With 34.70K shares outstanding, the current market capitalization sits at 41.08B.
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RWM18.050.14
+0.78%
ProShares Short Russell2000
LYLD26.950.07
+0.26%
Cambria LargeCap Shareholder Yield ETF
DNP9.840.01
+0.10%
DNP Select Income Fund
HYBL28.51-0.02
-0.09%
SPDR® Blackstone High Income ETF
LITP7.85-0.30
-3.68%
Sprott Lithium Miners ETF

ARGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ARGNF. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
-0.67%
ARGNF - ARGX
55%
Loosely correlated
N/A
IONS - ARGX
41%
Loosely correlated
-2.19%
ROIV - ARGX
40%
Loosely correlated
-0.42%
ALNY - ARGX
40%
Loosely correlated
+0.31%
AXON - ARGX
40%
Loosely correlated
-4.21%
More